Work

The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus

Year: 2013

Type: article

Source: Cancer Gene Therapy

DOI: 10.1038/cgt.2013.38

Authors: K Fujii, K Kurozumi, T Ichikawa, M Onishi, Y Shimazu, J Ishida, E A Chiocca, B Kaur, I Date

Institutions: Okayama University, Brigham and Women's Hospital, The Ohio State University

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Japan Society for the Promotion of Science, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: OV therapy induced changes in tumor secretome and their impact on therapy, Ohio State Neuroscience Center Core, Enhancing viral oncolysis with vasculostatin gene delivery, Combination therapy of oncolytic virus & antiangiogenic drug for malignant glioma, Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas

OpenAlex ID: W2083100228

FWCI: 1.536

Cites: 35

Cited by: 26

Related to: 10